These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 16138637)

  • 41. Effect of therapy with insulin glargine (lantus) on glycemic control in toddlers, children, and adolescents with diabetes.
    Hathout EH; Fujishige L; Geach J; Ischandar M; Maruo S; Mace JW
    Diabetes Technol Ther; 2003; 5(5):801-6. PubMed ID: 14633345
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FreeStyle navigator continuous glucose monitoring system use in children with type 1 diabetes using glargine-based multiple daily dose regimens: results of a pilot trial Diabetes Research in Children Network (DirecNet) Study Group.
    Weinzimer S; Xing D; Tansey M; Fiallo-Scharer R; Mauras N; Wysocki T; Beck R; Tamborlane W; Ruedy K;
    Diabetes Care; 2008 Mar; 31(3):525-7. PubMed ID: 18096811
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Optimised glycaemic control and dose titration with insulin glargine (Lantus) by general practitioners in Switzerland: results of the OPTI-LAN Postmarketing Study].
    Spirk D; Lareida J; Scheidegger K; Diem P
    Praxis (Bern 1994); 2009 Mar; 98(6):315-20. PubMed ID: 19291638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insulin pump therapy for type 1 diabetes treatment in a girl with Down's syndrome.
    Scaramuzza AE; Giani E; Riboni S; Spiri D; De Palma A; Mameli C; Zuccotti GV
    Diabetes Res Clin Pract; 2009 Aug; 85(2):e16-8. PubMed ID: 19595363
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nocturnal glucose control and free insulin levels in children with type 1 diabetes by use of the long-acting insulin HOE 901 as part of a three-injection regimen.
    Mohn A; Strang S; Wernicke-Panten K; Lang AM; Edge JA; Dunger DB
    Diabetes Care; 2000 Apr; 23(4):557-9. PubMed ID: 10857953
    [No Abstract]   [Full Text] [Related]  

  • 46. Efficacy and safety of insulin glulisine in Japanese patients with type 1 diabetes mellitus.
    Kawamori R; Kadowaki T; Ishii H; Iwasaki M; Iwamoto Y
    Diabetes Obes Metab; 2009 Sep; 11(9):891-9. PubMed ID: 19614947
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of oral insulin spray and subcutaneous regular insulin at mealtime in type 1 diabetes.
    Guevara-Aguirre J; Guevara-Aguirre M; Saavedra J; Bernstein G; Rosenbloom AL
    Diabetes Technol Ther; 2007 Aug; 9(4):372-6. PubMed ID: 17705693
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.
    Imbergamo MP; Amato MC; Sciortino G; Gambina M; Accidenti M; Criscimanna A; Giordano C; Galluzzo A
    Clin Ther; 2008 Aug; 30(8):1476-84. PubMed ID: 18803989
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The insulin analog glargine during an unplanned pregnancy.
    Cechurová D; Lacigová S; Jankovec Z; Haladová I; Zourek M; Krcma M; Rusavý Z; Turek J
    Wien Klin Wochenschr; 2006 Oct; 118(19-20):619-20. PubMed ID: 17136338
    [No Abstract]   [Full Text] [Related]  

  • 50. [Long-term evaluation of patients with type 1 diabetes mellitus treated with insulin glargine].
    Haladová I; Lacigová S; Cechurová D; Jankovec Z; Krcma M; Rusavý Z
    Vnitr Lek; 2009 Nov; 55(11):1016-21. PubMed ID: 20017431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contribution of postprandial versus interprandial blood glucose to HbA1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime.
    Ciofetta M; Lalli C; Del Sindaco P; Torlone E; Pampanelli S; Mauro L; Chiara DL; Brunetti P; Bolli GB
    Diabetes Care; 1999 May; 22(5):795-800. PubMed ID: 10332684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The rate of improvement in metabolic control in children with diabetes mellitus type 1 on insulin glargine depends on age.
    Deja G; Jarosz-Chobot P; Polanska J
    Exp Clin Endocrinol Diabetes; 2007 Nov; 115(10):662-8. PubMed ID: 18058601
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Technology and Pregnancy.
    Yamamoto JM; Murphy HR
    Diabetes Technol Ther; 2018 Feb; 20(S1):S94-S103. PubMed ID: 29437483
    [No Abstract]   [Full Text] [Related]  

  • 54. Insulin therapy for type 2 diabetes: rescue, augmentation, and replacement of beta-cell function.
    Mayfield JA; White RD
    Am Fam Physician; 2004 Aug; 70(3):489-500. PubMed ID: 15317436
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is basal insulin always the first choice for initiation of insulin therapy in type 2 diabetic patients?
    Mannucci E; Monami M; Masotti G; Marchionni N
    Exp Clin Endocrinol Diabetes; 2007 May; 115(5):339-40. PubMed ID: 17516300
    [No Abstract]   [Full Text] [Related]  

  • 56. Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia.
    Johansen OE; Vanberg PJ; Kilhovd BK; Jørgensen AP
    Vasc Health Risk Manag; 2009; 5(1):121-8. PubMed ID: 19436668
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [How should we use the short-acting insulin analog Lys-Pro in external continuous subcutaneous pumps?].
    Guerci B; Jeandidier N; Lassmann-Vague V; Renard E; Hanaire-Broutin H
    Diabetes Metab; 2000 Dec; 26(6):513-9. PubMed ID: 11173725
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of breakfast and bedtime administration of insulin glargine in children and adolescents with Type 1 diabetes.
    Karagüzel G; Satilmiş A; Akçurin S; Bircan I
    Diabetes Res Clin Pract; 2006 Oct; 74(1):15-20. PubMed ID: 16621116
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin glargine in the treatment of type 1 and type 2 diabetes.
    Barnett AH
    Vasc Health Risk Manag; 2006; 2(1):59-67. PubMed ID: 17319470
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of inhaled insulin on patient-reported outcomes and treatment preference in patients with type 1 diabetes.
    Hayes RP; Muchmore D; Schmitke J
    Curr Med Res Opin; 2007 Feb; 23(2):435-42. PubMed ID: 17288697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.